J Neurol Neurosurg Psychiatry. Published Online First: 29 November 2006. doi:10.1136/jnnp.2006.104042
Original articles |
Achieved serum magnesium concentrations and occurrence of delayed cerebral ischaemia and poor outcome in aneurysmal subarachnoid haemorrhage
1 University Medical Center Utrecht, Netherlands
2 University Medical Center Utrecht and Julius Center for General Practice and Patient-oriented Resear, Netherlands
3 University Center Utrecht, Netherlands
* To whom correspondence should be addressed. E-mail: s.m.dorhoutmees{at}umcutrecht.nl.
Accepted 17 November 2006
Abstract
Background: Magnesium therapy probably reduces the frequency of delayed cerebral ischaemia (DCI) in subarachnoid haemorrhage (SAH), but uncertainty remains about the optimal serum magnesium concentration. We assessed the relationship between serum magnesium concentrations achieved with magnesium sulphate therapy 64 mmol per day and the occurrence of delayed cerebral ischemia (DCI) and poor outcome in SAH patients.
Methods: Differences in magnesium concentrations between patients with and without DCI and with and without poor outcome were calculated. Quartiles of last serum magnesium concentrations before onset of DCI, or before median day of DCI in patients without DCI, were related with the occurrence of DCI and poor outcome at 3 months with logistic regression.
Results: Compared with the lowest quartile of serum magnesium concentration (1.10 - 1.28 mmol/L), the risk of DCI was decreased in each of the higher 3 quartiles (adjusted odds ratio (OR) in each quartile 0.2; lower 95% confidence limit 0.0 to 0.1; upper limit 0.8-0.9). The OR for poor outcome was 1.8 (95% CI 0.5-6.9) in the 2nd quartile, 1.0 (95% CI 0.2-4.5) in the 3rd quartile, and 4.9 (95% CI 1.2-19.7) in the highest quartile.
Discussion: Magnesium sulphate 64 mmol/day results in stable risk reduction of DCI in a broad range of achieved serum magnesium concentrations, and strict titration of the dosage therefore seems not necessary. However, concentrations 
1.28 mmol/L could decrease the effect on DCI while concentrations 
1.62 might have a negative effect on clinical outcome.
Keywords: delayed cerebral ischaemia, magnesium sulphate, subarachnoid haemorrhage
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
- Full Text (Rapid PDF)
-
All Versions of this Article:
jnnp.2006.104042v1
78/7/729 most recent - Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
Services
- Email this link to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
Citing Articles
Google Scholar
PubMed
Bookmark with
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
